Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional imaging in dementia: an overview

W J Jagust1

  • 1U.C. Davis Alzheimer's Center, Department of Neurology, University of California, Davis.

The Journal of Clinical Psychiatry
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.

European journal of nuclear medicine and molecular imaging·2014
Same author

Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013.

Clinical EEG and neuroscience·2013
Same author

Functional Neuroimaging of Cortical Dysfunction in Alcoholic Korsakoff's Syndrome.

Journal of cognitive neuroscience·2013
Same author

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.

Molecular psychiatry·2013
Same author

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

Neurology·2011
Same author

Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.

Neurology·2011
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

This review covers dementia diagnosis, emphasizing the exclusion of reversible causes. Functional brain imaging like PET and SPECT can aid diagnosis after ruling out treatable conditions.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Dementia diagnosis involves excluding treatable causes.
  • Structural brain imaging (MRI, CT) is crucial for identifying reversible lesions.

Purpose of the Study:

  • To review the clinical approach to dementia.
  • To discuss the role of functional brain imaging in dementia evaluation.

Main Methods:

  • Review of clinical guidelines and imaging literature.
  • Discussion of functional imaging techniques: Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).

Main Results:

  • Structural imaging is primary for ruling out reversible causes.
  • Functional imaging offers supplementary data for dementia etiology after reversible conditions are excluded.

Related Experiment Videos

Conclusions:

  • Functional imaging (PET, SPECT) can provide valuable insights into dementia causes.
  • Interpretation of functional imaging requires clinical context, and supporting data limitations persist.